Company News

This press release is posted as a service by Angioplasty.Org

Toshiba Achieves Educational Milestone for Unique Physican-to-Physician Speakers Bureau Program

TUSTIN, Calif., May 9, 2006 – Ensuring that patients across the country have access to the best cardiac care available, Toshiba America Medical Systems, Inc. (TAMS) today announced that it has successfully enrolled more than 2,500 radiologists and cardiologists in its national speakers bureau program and physician training courses through the Toshiba Education Center. The Toshiba Speakers Bureau, which was launched in 2004, features leading physician presenters and is designed to educate physicians about latest cardiac imaging technology, including the Aquilion 64TM CFX computed tomography (CT) system, the InfinixTM-i series of cath labs and the AplioTM ultrasound system.

Offered nationwide, Toshiba's Speakers Bureau events are continuing medical education (CME) programs accredited by the Accreditation Council for Continuing Medical Education (ACCME) and aimed at relaying the practical experiences of clinicians that have adopted 64-slice CT technology in a wide variety of settings, from hospitals to stand-alone imaging centers. From Sept. 2004 through March 2006, Toshiba has hosted nearly 30 speakers bureau event in cities across the country, including Anaheim, Baltimore, Chicago and Miami.

According to Peter Fail, M.D., cardiologist, Cardiovascular Institute of the South, the growing availability of technology designed to diagnose heart disease before a patient experiences a heart attack has put new demands on the fields of cardiology and radiology. “Patients are actively looking for the next best thing when it comes to uncovering their true risk for heart disease.

Diagnostic imaging is a big part of that equation, making it essential for physicians to remain up to date on the latest imaging applications in cardiology, such as 64-slice CT.”

“The real-life experiences of cardiologists, including everything from workflow to reimbursement, are the best learning tools for those with questions about the technology,” said Robb Young, senior manager, cardiology CT, Toshiba. “Additionally, having these events take place all over the country is a great way to make sure every clinician has access to the latest information about new and emerging techniques in cardiac imaging, regardless of their location.”

Toshiba’s Full Line of Cardiac Imaging Technology
Toshiba offers a comprehensive line of cardiac imaging technologies designed to diagnose and help treat a wide range of cardiac abnormalities. Anchored by the company’s flagship cardiac CT system, the Aquilion 64 CFX, Toshiba’s cardiac offerings are available in every diagnostic imaging category and include the Excelart Vantage ZGV MRI system, Aplio CV ultrasound system and the Infinix-i series of cath labs. For more information about Toshiba and its wide range of cardiac imaging products, please visit

About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 161,000 employees worldwide and annual sales of $53 billion.

Aquilion™, Infinix™-i series and Aplio™ are trademarks of Toshiba Medical Systems Corporation

Source: Toshiba America Medical Systems, Inc.

Angioplasty.Org Home •  PatientCenter

this press release is posted as a reader service by,
an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2021